{
  "entities": {
    "activities": {
      "c1abbbed-eb18-44ca-a000-5ce67d501e83": "Apheresis",
      "f59ebe06-047b-4637-882f-01238b7a0e4d": "Blood Sampling",
      "2f9dc811-080d-4817-ba1f-8769ebe255e1": "Chest Radiograph",
      "502fedbf-ff4a-431b-9466-2641a1e0303e": "Clinical remission and not receiving concomitant corticosteroids at Week 44",
      "4e14d8ae-ebe4-4bda-9993-20095c4a9083": "Electrocardiogram",
      "84df9ec6-dd14-4635-b493-60b7aed872ee": "Endoscopic healing at Week 44",
      "6d42a5e0-1113-4ea2-928a-0e4b91ab1198": "Endoscopy",
      "f5052998-af10-4830-86b9-74f533c48006": "Fecal Sample Collection",
      "9a4289c3-d8d0-4aee-ac68-96dcc156b7ce": "Intravenous Infusion",
      "4f8eedfa-87eb-4de8-8657-83abc1e6432a": "Maintenance of clinical remission through Week 44 among the subjects who had achieved clinical remission at maintenance baseline (both global and US definitions)",
      "2c5ba673-525f-4641-932c-21607862969c": "Maintenance of clinical response through Week 44",
      "d73d0756-e377-4eae-b10b-8128282e78a0": "Mucosal Biopsy",
      "9d41862e-e921-4723-9c61-0076c4ff3c2f": "Physical Examination",
      "f696681f-375a-458d-9cb5-483187ef6903": "QuantiFERON-TB Gold Test",
      "485c820f-1d15-4265-9344-03aa584cd01e": "Subcutaneous Injection",
      "0b34fb41-4f2c-4f94-94bf-fa6b86c924df": "Tuberculin Skin Test",
      "848621d0-e4dd-442c-8471-8aba94f89215": "Vital Signs Monitoring"
    },
    "plannedTimepoints": {},
    "encounters": {
      "1172c21e-fda8-42eb-9223-1bb41d2d861a": "Placebo SC",
      "b648f635-e6c4-479d-b69b-4e7438195819": "Ustekinumab 90 mg SC q12w",
      "5af60448-b034-4eb4-a88e-f34204fa0ab2": "Ustekinumab 90 mg SC q8w"
    },
    "epochs": {
      "5e5b78a3-edff-4a3f-96f5-aecbac3374bd": "Maintenance Study"
    },
    "activityGroups": {}
  },
  "cells": {
    "2c5ba673-525f-4641-932c-21607862969c|1172c21e-fda8-42eb-9223-1bb41d2d861a": "both",
    "2c5ba673-525f-4641-932c-21607862969c|b648f635-e6c4-479d-b69b-4e7438195819": "both",
    "2c5ba673-525f-4641-932c-21607862969c|5af60448-b034-4eb4-a88e-f34204fa0ab2": "both",
    "84df9ec6-dd14-4635-b493-60b7aed872ee|1172c21e-fda8-42eb-9223-1bb41d2d861a": "both",
    "84df9ec6-dd14-4635-b493-60b7aed872ee|b648f635-e6c4-479d-b69b-4e7438195819": "both",
    "84df9ec6-dd14-4635-b493-60b7aed872ee|5af60448-b034-4eb4-a88e-f34204fa0ab2": "both",
    "502fedbf-ff4a-431b-9466-2641a1e0303e|1172c21e-fda8-42eb-9223-1bb41d2d861a": "both",
    "502fedbf-ff4a-431b-9466-2641a1e0303e|b648f635-e6c4-479d-b69b-4e7438195819": "both",
    "502fedbf-ff4a-431b-9466-2641a1e0303e|5af60448-b034-4eb4-a88e-f34204fa0ab2": "both",
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|1172c21e-fda8-42eb-9223-1bb41d2d861a": "both",
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|b648f635-e6c4-479d-b69b-4e7438195819": "both",
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|5af60448-b034-4eb4-a88e-f34204fa0ab2": "both"
  },
  "cellFootnotes": {
    "2c5ba673-525f-4641-932c-21607862969c|5af60448-b034-4eb4-a88e-f34204fa0ab2": [
      "a"
    ],
    "84df9ec6-dd14-4635-b493-60b7aed872ee|5af60448-b034-4eb4-a88e-f34204fa0ab2": [
      "a"
    ],
    "502fedbf-ff4a-431b-9466-2641a1e0303e|5af60448-b034-4eb4-a88e-f34204fa0ab2": [
      "a"
    ],
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|1172c21e-fda8-42eb-9223-1bb41d2d861a": [
      "b"
    ],
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|b648f635-e6c4-479d-b69b-4e7438195819": [
      "b"
    ],
    "4f8eedfa-87eb-4de8-8657-83abc1e6432a|5af60448-b034-4eb4-a88e-f34204fa0ab2": [
      "a",
      "b"
    ]
  },
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}